Who Paid My Doc
Margenza
Drug Oncology
NDC 74527-022-02
General payments
$45,935
Research payments
$8,402,173
Through program year 2024, $45,935 in general payments and $8,402,173 in research payments were reported against Margenza (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $867 | 13 |
| 2024 | Research | $2,086,151 | 23 |
| 2023 | General | $3,448 | 111 |
| 2023 | Research | $1,961,481 | 94 |
| 2022 | General | $16,157 | 274 |
| 2022 | Research | $1,829,929 | 391 |
| 2021 | General | $25,463 | 78 |
| 2021 | Research | $2,524,611 | 281 |
Breakdown
The top 5 of 12 recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 7 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
476 general · 789 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.